Helmholtz Gemeinschaft


A brief introduction to current cancer gene therapy

Item Type:Article
Title:A brief introduction to current cancer gene therapy
Creators Name:Kobelt, D. and Pahle, J. and Walther, W.
Abstract:Gene therapy has started in the late 1980s as novel, clinically applicable therapeutic option. It revolutionized the treatment of genetic diseases with the initial intent to repair or replace defective genes. Gene therapy has been adapted for treatment of malignant diseases to improve the outcome of cancer patients. In fact, cancer gene therapy has rapidly gained great interest and evolved into a research field with highest proportion of research activities in gene therapy. In this context, cancer gene therapy has long entered translation into clinical trials and therefore more than two-thirds of all gene therapy trials worldwide are aiming at the treatment of cancer disease using different therapeutic strategies. During the decades in cancer gene therapy, tremendous knowledge has accumulated. This led to significant improvements in vector design, transgene repertoire, more targeted interventions, use of novel gene therapeutic technologies such as CRISPR/Cas, sleeping beauty vectors, and development of effective cancer immunogene therapies. In this chapter, a brief overview of current key developments in cancer gene therapy is provided to gain insights into the recent directions in research as well as in clinical application of cancer gene therapy.
Keywords:Gene Therapy, Cancer, Genetic Engineering, Gene Transfer, Transgenes, Cell Therapy
Source:Methods in Molecular Biology
Series Name:Methods in Molecular Biology
Title of Book:Gene therapy of cancer : methods and protocols
Publisher:Springer / Humana Press
Page Range:1-21
Number of Pages:445
Date:23 June 2022
Official Publication:https://doi.org/10.1007/978-1-0716-2441-8_1
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Open Access
MDC Library